OCTV compared with TBPH: revenue, margins and what each company keeps, and the suppliers and customers both name

OCTVOctave Intelligence plc

Mkt capRevenueRevenue

TBPHTheravance Biopharma, Inc.

Mkt capRevenueRevenue

Compare

OCTVOctave Intelligence plc

TBPHTheravance Biopharma, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

OCTV1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▼−3.25%—

TBPH

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±6.0%▼−0.12%×0.02

May 7 '26±10.3%▲+0.47%×0.05

= impliedOCTV realized, solidTBPH realized, hatchedOne scale, both sides: full bar = 25%× = |realized| ÷ impliedSource: market data

Q1 FY26

±12.0%

▲+1.30%

×0.11

Q3 FY25±24.6%▲+22.68%×0.92

OCTVOctave Intelligence plc

21.10▼−2.82%· post 21.10

Mkt cap$5.7BRevenue$398MQ2 FY26Revenue—

TBPHTheravance Biopharma, Inc.

17.03▲+0.02%· post 17.04

ClosedNov 2 '26

Mkt cap$884.2MRevenue$21MQ2 FY26Revenue$107MFY25

Compare

ClosedNov 2 '26

OCTVOctave Intelligence plc

TBPHTheravance Biopharma, Inc.

21.10▼−2.82%post 21.10

Price

17.03▲+0.02%post 17.04

$5.7B

Mkt cap

$884.2M

Q2 FY26$398M

Revenue

$21MQ2 FY26

—

Revenue

$107MFY25

OCTV21.10▼−2.82%vsTBPH17.03▲+0.02%ClosedNov 2 '26